|
Referenz |
Lieferant |
Beschreibung |
Einheit |
Preis exkl. MwSt. |
|
|
|
EPY0002212 |
European Pharmacopoeia |
DL-lysine acetylsalicylate impurity C 5mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002213 |
European Pharmacopoeia |
DL-lysine acetylsalicylate impurity G 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002214 |
European Pharmacopoeia |
Celiprolol for system suitability CRS 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002215 |
European Pharmacopoeia |
Primidone for system suitability CRS 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002216 |
European Pharmacopoeia |
Betiatide 20mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002217 |
European Pharmacopoeia |
Betiatide impurity D 10mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002218 |
European Pharmacopoeia |
Latanoprost CRS 100mg |
|
2,639.76 CHF
2,869.42 €
|
|
|
|
EPY0002219 |
European Pharmacopoeia |
Fluoxetine hydrochloride for ID and assay CRS 250mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002220 |
European Pharmacopoeia |
Monotropein CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002221 |
European Pharmacopoeia |
Ticagrelor impurity E |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002222 |
European Pharmacopoeia |
Ticagrelor |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002223 |
European Pharmacopoeia |
Ticagrelor For System Suitability |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002224 |
European Pharmacopoeia |
Sorafenib tosilate CRS |
|
194.48 CHF
211.40 €
|
|
|
|
EPY0002225 |
European Pharmacopoeia |
Regorafenib for FP system suitability CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002226 |
European Pharmacopoeia |
Forsythoside A CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002227 |
European Pharmacopoeia |
Regorafenib impurity FP-B CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002228 |
European Pharmacopoeia |
Regorafenib impurity FP-C CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002229 |
European Pharmacopoeia |
Atorvastatin for system suitability CRS 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002230 |
European Pharmacopoeia |
Morinda root for system suitabillity HRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002231 |
European Pharmacopoeia |
Prednicarbate for peak identification CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002232 |
European Pharmacopoeia |
Streptomycin sulfate for identification 25mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002233 |
European Pharmacopoeia |
Sorafenib impurity H |
|
240.72 CHF
261.66 €
|
|
|
|
EPY0002234 |
European Pharmacopoeia |
Dexpanthenol impurity B CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002235 |
European Pharmacopoeia |
Piperacillin for peak identification CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002236 |
European Pharmacopoeia |
Sorafenib for peak identification |
|
240.72 CHF
261.66 €
|
|
|
|
EPY0002237 |
European Pharmacopoeia |
Piperacillin impurity I CRS 15mg |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002238 |
European Pharmacopoeia |
Riociguat CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002239 |
European Pharmacopoeia |
Riociguat for system suitability CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002240 |
European Pharmacopoeia |
Riociguat for FP system suitability CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002241 |
European Pharmacopoeia |
Piperacillin impurity N CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002242 |
European Pharmacopoeia |
Aciclovir for impurity C identification CRS |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0002243 |
European Pharmacopoeia |
Latanoprost - reference spectrum 1uc |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002244 |
European Pharmacopoeia |
Aciclovir for impurity G identification |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0002245 |
European Pharmacopoeia |
Aciclovir for system suitability A CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002246 |
European Pharmacopoeia |
Adrenaline impurity F CRS 0.008mg |
|
157.76 CHF
171.49 €
|
|
|
|
EPY0002247 |
European Pharmacopoeia |
Teriflunomide CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002248 |
European Pharmacopoeia |
Ibandronate sodium monohydrate CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002249 |
European Pharmacopoeia |
Fluticasone propionate for system suitability CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002250 |
European Pharmacopoeia |
Nickel solution |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002251 |
European Pharmacopoeia |
Clomifene for peak identification |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002252 |
European Pharmacopoeia |
Clomifene for impurities G and H identification |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002253 |
European Pharmacopoeia |
Teriflunomide for assay |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002254 |
European Pharmacopoeia |
Teriflunomide impurity B |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002255 |
European Pharmacopoeia |
Sulindac for system suitability |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002256 |
European Pharmacopoeia |
Fludarabine for peak identification |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002257 |
European Pharmacopoeia |
Pemetrexed disodium 2.5-hydrate CRS |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002258 |
European Pharmacopoeia |
N-Nitroso-diethylamine |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002259 |
European Pharmacopoeia |
N-nitroso-dimethylamine |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002260 |
European Pharmacopoeia |
N-nitroso-N-methyl-4-aminobutyric acid |
|
152.32 CHF
165.57 €
|
|
|
|
EPY0002261 |
European Pharmacopoeia |
N-Nitroso-dibutylamine |
|
152.32 CHF
165.57 €
|
|
